{"id":"https://openalex.org/W2499861089","doi":"https://doi.org/10.1158/1538-7445.am2016-3867","title":"Abstract 3867: Combined PI3K and AURKA inhibition are efficacious in triple-negative breast cancer models","display_name":"Abstract 3867: Combined PI3K and AURKA inhibition are efficacious in triple-negative breast cancer models","publication_year":2016,"publication_date":"2016-07-15","ids":{"openalex":"https://openalex.org/W2499861089","doi":"https://doi.org/10.1158/1538-7445.am2016-3867","mag":"2499861089"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2016-3867","doi":"https://doi.org/10.1158/1538-7445.am2016-3867","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2016-3867","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5005079864","display_name":"Amanda E.D. Van Swearingen","orcid":"https://orcid.org/0000-0002-4287-9741","observed_orcids":["https://orcid.org/0000-0002-4287-9741"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amanda E.D. Van Swearingen","raw_affiliation_strings":["University of North Carolina at Chapel Hill, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of North Carolina at Chapel Hill, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085899762","display_name":"Maria J. Sambade","orcid":"https://orcid.org/0000-0002-6223-7324","observed_orcids":["https://orcid.org/0000-0002-6223-7324"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Maria J. Sambade","raw_affiliation_strings":["University of North Carolina at Chapel Hill, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of North Carolina at Chapel Hill, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112863970","display_name":"Shivani Sud","orcid":"https://orcid.org/0000-0002-7713-3771","observed_orcids":["https://orcid.org/0000-0002-7713-3771"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shivani Sud","raw_affiliation_strings":["University of North Carolina at Chapel Hill, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of North Carolina at Chapel Hill, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045554156","display_name":"Brian T. Golitz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brian Golitz","raw_affiliation_strings":["University of North Carolina at Chapel Hill, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of North Carolina at Chapel Hill, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047612906","display_name":"Gary L. Johnson","orcid":"https://orcid.org/0000-0003-2867-0551","observed_orcids":["https://orcid.org/0000-0003-2867-0551"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gary L. Johnson","raw_affiliation_strings":["University of North Carolina at Chapel Hill, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of North Carolina at Chapel Hill, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5013557141","display_name":"Carey K. Anders","orcid":"https://orcid.org/0000-0001-9165-4074","observed_orcids":["https://orcid.org/0000-0001-9165-4074"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Carey K. Anders","raw_affiliation_strings":["University of North Carolina at Chapel Hill, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of North Carolina at Chapel Hill, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I114027177"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"76","issue":"14_Supplement","first_page":"3867","last_page":"3867"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.9550999999046326,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.9550999999046326,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.011300000362098217,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11600","display_name":"Brain Metastases and Treatment","score":0.006899999920278788,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.9929999709129333},{"id":"https://openalex.org/keywords/brain-metastases","display_name":"brain metastases","score":0.9789999723434448},{"id":"https://openalex.org/keywords/pi3k-inhibition","display_name":"PI3K inhibition","score":0.9549999833106995},{"id":"https://openalex.org/keywords/bkm120","display_name":"BKM120","score":0.972000002861023},{"id":"https://openalex.org/keywords/mln8237","display_name":"MLN8237","score":0.9890000224113464},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.5389999747276306},{"id":"https://openalex.org/keywords/synthetic-lethality","display_name":"synthetic lethality","score":0.9620000123977661},{"id":"https://openalex.org/keywords/drug-synergy","display_name":"drug synergy","score":0.5609999895095825},{"id":"https://openalex.org/keywords/cell-cycle-progression","display_name":"cell cycle progression","score":0.5740000009536743},{"id":"https://openalex.org/keywords/blood-brain-barrier","display_name":"blood-brain barrier","score":0.7210000157356262},{"id":"https://openalex.org/keywords/sum149","display_name":"SUM149","score":0.6779999732971191},{"id":"https://openalex.org/keywords/mda-mb-468-cells","display_name":"MDA-MB-468","score":0.8489999771118164}],"concepts":[{"id":"https://openalex.org/C2780110267","wikidata":"https://www.wikidata.org/wiki/Q7843332","display_name":"Triple-negative breast cancer","level":4,"score":0.7812035083770752},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.639527440071106},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6023455858230591},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5842480063438416},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.484896719455719},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.43342986702919006},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.23209235072135925},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.1736127734184265},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.15482959151268005},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2016-3867","doi":"https://doi.org/10.1158/1538-7445.am2016-3867","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2016-3867","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1963640784","https://openalex.org/W2766183260","https://openalex.org/W2612444138","https://openalex.org/W2566936073","https://openalex.org/W7009705328","https://openalex.org/W4244656343","https://openalex.org/W4223543722","https://openalex.org/W2594665350","https://openalex.org/W4385577052","https://openalex.org/W4309779541"],"abstract_inverted_index":{"Abstract":[0],"Introduction:":[1],"Nearly":[2],"half":[3],"of":[4,42,61,65,76,86,118,127,132,138,147,281,397,449,454],"metastatic":[5],"triple":[6],"negative":[7],"breast":[8,52,443],"cancer":[9,444],"(TNBC)":[10],"patients":[11],"develop":[12],"brain":[13],"metastases":[14],"(BMs)":[15],"and":[16,46,67,91,104,134,136,163,169,187,195,199,202,209,286,313,436],"face":[17],"a":[18,221,290,303,314,381,385],"poor":[19],"prognosis.":[20],"There":[21],"are":[22,74,413,439],"no":[23],"FDA-approved":[24],"systemic":[25],"therapies":[26],"to":[27,34,50,114,216,257,265,296,342,348,355,363,370,404],"treat":[28],"TNBC":[29,70,100,205,401],"BM,":[30],"due":[31],"in":[32,69,78,97,166,170,174,193,227,235,247,259,270,277,283,327,335,399,441],"part":[33],"the":[35,43,59,79,87,125,130,139,145,232,236,253,284,328,331,395,406,450,455],"blood-brain":[36],"barrier.":[37],"BCBMs":[38],"exhibit":[39],"both":[40,336],"activation":[41],"PI3K":[44,66,186,435],"pathway":[45],"AURKA":[47,68,92,188,437],"amplification/overexpression":[48],"relative":[49],"primary":[51],"cancers.":[53],"In":[54,83,391],"this":[55],"study,":[56],"we":[57],"evaluate":[58],"efficacy":[60,126,396],"brain-penetrant,":[62],"clinically-available":[63],"inhibitors":[64],"cell":[71,101,153,206,337,365],"lines":[72,207,338],"that":[73,184],"capable":[75],"growing":[77],"mouse":[80,402],"brain.":[81],"Methods:":[82],"vitro":[84],"characterization":[85],"pan-PI3K":[88],"inhibitor":[89,93],"BKM120":[90,121,133,148,273,282],"MLN8237":[94,135,150,263,300,343,350],"were":[95,141,324,361],"conducted":[96,159],"2":[98],"human-derived":[99],"lines,":[102],"SUM149":[103,194,198,285],"(MDA-MB-)231Br.":[105],"A":[106],"siRNA":[107],"screen":[108,182],"(720":[109],"kinase":[110],"genes)":[111],"was":[112,158,220,243,255],"used":[113],"identify":[115],"synthetic":[116],"enhancers":[117],"lethality":[119,192],"with":[120,231,241,262,388],"treatment.":[122],"To":[123,143],"assess":[124],"these":[128],"drugs,":[129],"IC50s":[131,213,228],"synergy":[137,269,276],"combination":[140,254],"determined.":[142],"compare":[144],"effects":[146,323],"and/or":[149],"treatment":[151,240],"on":[152],"cycle":[154,366],"progression,":[155],"FACS":[156,279],"analysis":[157,280],"at":[160,249,306,310,319],"24,":[161],"48,":[162],"72":[164,297,320],"hours":[165],"parent":[167],"cells":[168,171,201,288],"continuously":[172,346],"cultured":[173],"MLN8237-treated":[175],"media":[176],"for":[177,229,358,384,409,458],"12":[178,359],"weeks.":[179],"Results:":[180],"The":[181],"confirmed":[183],"combined":[185],"inhibition":[189,376,438],"synthetically":[190],"enhanced":[191],"231Br":[196,200,237,287],"cells.":[197],"two":[203],"additional":[204],"(MDA-MB-468":[208],"MDA-MB-436)":[210],"exhibited":[211],"similar":[212,341],"(1.3-21":[214],"\u03bcM)":[215,226],"BKM120.":[217],"However,":[218],"there":[219],">2.5":[222],"fold":[223],"range":[224],"(26.5-69":[225],"MLN8237,":[230],"greatest":[233],"potency":[234],"line.":[238],"Concurrent":[239],"BKM120+MLN8237":[242,267,334,398],"synergistic":[244],"or":[245],"additive":[246,256],"231Brs":[248,329],"most":[250],"doses,":[251],"whereas":[252],"antagonistic":[258],"SUM149s.":[260,332],"Pretreatment":[261],"prior":[264],"concurrent":[266],"improved":[268,275],"SUM149s,":[271],"while":[272,299],"pretreatment":[274],"231Brs.":[278],"induced":[289,302],"slight":[291],"G1":[292],"arrest":[293,305],"from":[294,352],"24":[295,307],"hours,":[298,308,312],"initially":[301],"G2":[304],"polyploidy":[309],"48":[311],"mixed":[315],"polypoid/G2":[316],"arrested":[317],"population":[318,387],"hours.":[321],"These":[322],"more":[325],"pronounced":[326],"than":[330],"Combined":[333,374,434],"yielded":[339],"results":[340],"alone.":[344],"Cells":[345],"exposed":[347],"increasing":[349],"concentrations":[351],"50":[353],"nM":[354,357],"300":[356],"weeks":[360],"resistant":[362],"MLN8237-induced":[364],"changes":[367],"as":[368],"compared":[369],"passage-matched":[371],"controls.":[372],"Conclusions:":[373],"PI3K+AURKA":[375],"using":[377],"brain-penetrant":[378],"compounds":[379],"is":[380],"promising":[382],"strategy":[383],"patient":[386],"few":[389],"options.":[390],"vivo":[392],"studies":[393,412],"evaluating":[394],"intracranial":[400],"models":[403],"provide":[405],"translational":[407],"foundation":[408],"future":[410],"clinical":[411],"warranted.":[414],"Citation":[415],"Format:":[416],"Amanda":[417],"E.D.":[418],"Van":[419],"Swearingen,":[420],"Maria":[421],"J.":[422],"Sambade,":[423],"Shivani":[424],"Sud,":[425],"Brian":[426],"Golitz,":[427],"Gary":[428],"L.":[429],"Johnson,":[430],"Carey":[431],"K.":[432],"Anders.":[433],"efficacious":[440],"triple-negative":[442],"models.":[445],"[abstract].":[446],"In:":[447],"Proceedings":[448],"107th":[451],"Annual":[452],"Meeting":[453],"American":[456],"Association":[457],"Cancer":[459,470],"Research;":[460],"2016":[461],"Apr":[462],"16-20;":[463],"New":[464],"Orleans,":[465],"LA.":[466],"Philadelphia":[467],"(PA):":[468],"AACR;":[469],"Res":[471],"2016;76(14":[472],"Suppl):Abstract":[473],"nr":[474],"3867.":[475]},"counts_by_year":[],"updated_date":"2026-09-21T07:43:02.447757","created_date":"2016-08-23T00:00:00"}